Bracco, the market leader in diagnostic imaging and the pioneer in cardiac positron emission tomography (PET) for more than ...
Nuclear cardiac testing is most appropriate in the diagnosis of CAD in patients who have an intermediate likelihood of disease. Low-risk patients may need no additional testing, while high-risk ...
One of the leading causes of death worldwide is cardiovascular diseases. In efforts to manage these heart-related diseases, eight techniques have been defined to help doctors more optimally use ...
The United States will likely adopt the strategies that other countries have already implemented to reduce radiation exposure related to myocardial perfusion imaging, which accounts for a major ...
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has delivered the first patient doses of Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission ...
The United States has much greater use of myocardial perfusion imaging (MPI) compared with other parts of the world, but at the same time, US nuclear cardiology labs lag behind in adhering to best ...
Based on the clinical and scientific evidence now available, there are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded.” — Timothy Bateman, ...
Please provide your email address to receive an email when new articles are posted on . Coronary CTA is as useful as direct invasive coronary angiography when evaluating stable chest pain. Coronary CT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results